Skip to content

A randomized controlled trial for three thyroid surgery methods in the treatment of unilateral thyroid cancer

A randomized controlled trial for three thyroid surgery methods in the treatment of unilateral thyroid cancer

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020669
Enrollment
Unknown
Registered
2019-01-12
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid cancer

Interventions

Oral vestibular approach group:Surgical treatment of unilateral thyroid cancer via oral vestibular approach
Miccoli group:Miccoli unilateral thyroid cancer surgery
Traditional open access group:Traditional open approach unilateral thyroid cancer surgery

Sponsors

Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with unilaterally differentiated thyroid cancer aged 18-60 years; 2. The maximum diameter of the mass is <3 cm; 3. The patient has agreed to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Undifferentiated thyroid cancer; 2. bilateral thyroid surgery; 3. Patients with unilateral thyroid benign tumors; 4. Secondary hyperthyroidism; 5. Preoperative anesthesia score is higher than ASA III; 6. Allergies and contraindications to the drugs used in this test; 7. With severe coagulopathy, nervous system diseases or infectious diseases; 8. With serious heart, liver, kidney and blood system diseases; 9. With history of surgery in the neck.

Design outcomes

Primary

MeasureTime frame
Postoperative pain score;Postoperative cosmetic score;Postoperative inflammation index;

Secondary

MeasureTime frame
operation time;Intraoperative blood loss;First day after delivery;Number of lymph nodes and positive lymph nodes (based on postoperative pathology);Miscuts of parathyroid glands (based on postoperative pathology);The number of days in hospital;Incision infection;Postoperative bleeding;Whether to relapse;

Countries

China

Contacts

Public ContactWu Bo

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

wubo_2932@163.com+86 18930172932

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026